For this purpose, we used the SH-SY5Y cell line, a heterogenous NB model with known tumorigenicity comprising of YAP+ and YAP− subpopulations24, and frequently employed in NB differentiation and pre-clinical studies31. Here, YAP1 is linked to neuroblastoma.